Comprehensive meta-analysis of 87 randomized trials demonstrates that each 48 g/day increase in whole-grain intake reduces multiple cardiometabolic risk factors including weight, waist circumference, total and LDL cholesterol, triglycerides, fasting glucose, systolic blood pressure, and inflammatory marker interleukin-6.
High-certainty evidence supports reductions in adiposity, total cholesterol, and inflammation, while moderate-certainty evidence supports improvements in LDL cholesterol, triglycerides, glucose, and systolic blood pressure.
Non-linear dose-response analysis indicates maximal benefits commonly occur at whole-grain intakes of 60–100 g/day, with limited data to clarify effects beyond this range.
Evidence extends to prospective cohort data suggesting that specific whole-grain foods, such as cold breakfast cereals and bran, may reduce ischemic stroke risk, though results for overall stroke risk are inconclusive.
Background
MedXY registered readers
Sign in free to continue reading
Create or use your MedXY account to unlock the complete article.
This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.
